Identification and Protein Engineering of Galactosidases for the Conversion of Blood Type B to Blood Type O
ChemBioChem · 2025
DOI: 10.1002/cbic.202500072 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Christina Möller und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Department of Biotechnology and Enzyme Catalysis, University Greifswald, Felix-Hausdorff-Straße 4, 17487, Greifswald, Germ…. Hauptthemen laut MEDLINE: Protein Engineering, Galactosidases, ABO Blood-Group System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation DFG.
Abstract (Originalsprache)
The supply of blood products such as red blood cells poses a challenge due to rising demand and declining donor numbers. Careful matching of blood products of different types is required. Only type O of the blood types A, B, AB and O can be received by any patient without transfusion incompatibilities. Therefore, O‐type blood can be considered “universal blood” and is especially needed in emergency situations. In this study, we focused on the conversion of the B antigen by enzymatic deglycosylation to generate the H antigen determining O‐type blood. For this, we characterized several previously unstudied α‐1,3‐galactosidases belonging to the GH110 family. Our findings revealed that the α‐1,3‐galactosidase from Pedobacter panaciterrae (PpaGal) exhibits superior efficiency compared to previously described galactosidases. We further increased the activity of PpaGal by 2.5‐fold using site‐directed mutagenesis. Moreover, we solved two crystal structures of PpaGal, one in the apo‐state and another in complex with d ‐galactose. The combination of our mutagenesis study with the solved crystal structures provides valuable information to guide further optimization of PpaGal or other B antigen converting enzymes paving the way for the easier production of universal blood from B‐type blood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, Department of Biotechnology and Enzyme Catalysis, University Greifswald, Felix-Hausdorff-Straße 4, 17487, Greifswald, Germany.
- Institute of Biochemistry, Department of Synthetic and Structural Biochemistry, Felix-Hausdorff-Strasse 2, 17489, Greifswald, Germany.
- Institute of Transfusion Medicine, University Medicine Greifswald, Sauerbruchstrasse, 17475, Greifswald, Germany.
ORCID-Profile: Christina Möller, Henrik Terholsen, Ole Schmöker, Thi Linh Anne Lê, Jan Wesche, Niklas Rimkus, Dominique Böttcher, Gottfried J Palm, Michael Lammers, Andreas Greinacher, Konstanze Aurich, Uwe T Bornscheuer
Förderung
- German Research Foundation DFG
Zitieren
APA
Möller, C., Terholsen, H., Schmöker, O., Lê, T. L. A., Wesche, J., Schmiade, P., Eppendorfer, E., Rimkus, N., Girbardt, B., Böttcher, D., Palm, G. J., Hoppen, J., Lammers, M., Greinacher, A., Aurich, K., & Bornscheuer, U. T. (2025). Identification and Protein Engineering of Galactosidases for the Conversion of Blood Type B to Blood Type O. ChemBioChem. https://doi.org/10.1002/cbic.202500072
Vancouver
Möller C, Terholsen H, Schmöker O, Lê TLA, Wesche J, Schmiade P, et al. Identification and Protein Engineering of Galactosidases for the Conversion of Blood Type B to Blood Type O. ChemBioChem. 2025. doi:10.1002/cbic.202500072
BibTeX
@article{Mller2025,
author = {Möller, Christina and Terholsen, Henrik and Schmöker, Ole and Lê, Thi Linh Anne and Wesche, Jan and Schmiade, Paula and Eppendorfer, Esther and Rimkus, Niklas and Girbardt, Britta and Böttcher, Dominique and Palm, Gottfried J and Hoppen, Jens and Lammers, Michael and Greinacher, Andreas and Aurich, Konstanze and Bornscheuer, Uwe T},
title = {Identification and Protein Engineering of Galactosidases for the Conversion of Blood Type B to Blood Type O},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500072}
}
EUVIMED